Work

Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations

Year: 2021

Type: article

Source: Leukemia

DOI: 10.1038/s41375-021-01230-4

Authors: Roland B. Walter, Yishai Ofran, Agnieszka Wierzbowska, Farhad Ravandi, Christopher S. Hourigan, Lok Lam Ngai, Adriano Venditti, Francesco Buccisano, Gert J. Ossenkoppele, Gail J. Roboz

Institutions: University of Washington, Fred Hutch Cancer Center, Shaare Zedek Medical Center, Medical University of Lodz, The University of Texas MD Anderson Cancer Center, National Institutes of Health, National Heart, Lung, and Blood Institute, Amsterdam University Medical Centers, Amsterdam UMC Location Vrije Universiteit Amsterdam, University of Rome Tor Vergata, NewYork–Presbyterian Hospital, Cornell University, Weill Cornell Medicine

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute

OpenAlex ID: W3137653025

FWCI: 8.885

Cites: 65

Cited by: 81

Related to: 10